1. Hua, Zhongyan, Chen, Bo, Gong, Baocheng, Ma, Yifan, Li, Zhijie. . SESN1 functions as a new tumor suppressor gene via Toll-like receptor signaling pathway in neuroblastoma. In CNS neuroscience & therapeutics, 30, e14664. doi:10.1111/cns.14664. https://pubmed.ncbi.nlm.nih.gov/38516781/
2. Howe, Orla, White, Lisa, Cullen, Daniel, Badie, Christophe, Lyng, Fiona M. 2021. A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient Radiosensitivity. In International journal of molecular sciences, 22, . doi:10.3390/ijms221910607. https://pubmed.ncbi.nlm.nih.gov/34638945/
3. Jing, Ying, Zuo, Yuesheng, Sun, Liang, Liu, Guang-Hui, Wang, Si. 2023. SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing. In Cell proliferation, 56, e13455. doi:10.1111/cpr.13455. https://pubmed.ncbi.nlm.nih.gov/37199024/
4. Peeters, Hilde, Voz, Marianne L, Verschueren, Kristin, Peers, Bernard, Devriendt, Koen. 2006. Sesn1 is a novel gene for left-right asymmetry and mediating nodal signaling. In Human molecular genetics, 15, 3369-77. doi:. https://pubmed.ncbi.nlm.nih.gov/17038485/
5. Guo, Shaobo, Zhu, Wenhui, Bian, Yuting, Ji, Xuzheng, Zhang, Biao. 2024. Developing diagnostic biomarkers for Alzheimer's disease based on histone lactylation-related gene. In Heliyon, 10, e37807. doi:10.1016/j.heliyon.2024.e37807. https://pubmed.ncbi.nlm.nih.gov/39315143/
6. El Baroudi, Mariama, Machiels, Jean-Pascal, Schmitz, Sandra. 2017. Expression of SESN1, UHRF1BP1, and miR-377-3p as prognostic markers in mutated TP53 squamous cell carcinoma of the head and neck. In Cancer biology & therapy, 18, 775-782. doi:10.1080/15384047.2017.1373212. https://pubmed.ncbi.nlm.nih.gov/28886272/
7. Zhang, Chi, Ren, Lin, Zhang, Hongjian, Zhao, Chuanjiang, Xia, Juan. 2022. SESN1, negatively regulated by miR-377-3p, suppresses invasive growth of head and neck squamous cell carcinoma by interaction with SMAD3. In Human cell, 35, 1100-1113. doi:10.1007/s13577-022-00719-z. https://pubmed.ncbi.nlm.nih.gov/35622213/
智鼠故事 
